Tilray, Inc stock page - price, fundamentals, dividends - iOCharts

APHA

17.23
-0.60 (-3.39%)
Tilray, Inc (NASDAQ, USD)
Healthcare >
Drug Manufacturers-Specialty & Generic
Market cap
5.46B
Ent value
6.43B
Price/Sales
8.93
Price/Book
3.48
Div yield
-
Div growth
-
Growth years
-
FCF payout
-40.76%
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
300.70%
3 year return
23.40%
5 year return
70.48%
10 year return
-
Last updated: 2021-10-20

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open17.83
Daily high17.91
Daily low17.19
Daily Volume13.0M
All-time high26.30
1y analyst estimate-
Beta2.62
EPS (TTM)-1.85
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
APHAS&P500
Current price drop from All-time high-34.49%-
Highest price drop-88.46%-56.47%
Date of highest drop18 Mar 20209 Mar 2009
Avg drop from high-40.68%-11.45%
Avg time to new high20 days12 days
Max time to new high775 days1805 days

DIVIDENDS

APHA does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales8.93
Price to Book3.48
EV to Sales10.52

FINANCIALS

Per share

Loading...
Per share data
Current share count316.80M
EPS (TTM)-1.85
FCF per share (TTM)-0.46

Income statement

Loading...
Income statement data
Revenue (TTM)611.06M
Gross profit (TTM)164.51M
Operating income (TTM)-115.24M
Net income (TTM)-585.53M
EPS (TTM)-1.85
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)26.92%
Operating margin (TTM)-18.86%
Profit margin (TTM)-95.82%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash267.13M
Net receivables91.66M
Total current assets730.70M
Goodwill745.91M
Intangible assets669.70M
Property, plant and equipment644.71M
Total assets2.81B
Accounts payable58.22M
Short/Current long term debt881.91M
Total current liabilities216.99M
Total liabilities1.24B
Shareholder's equity1.57B
Net tangible assets92.35M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-74.17M
Capital expenditures (TTM)70.10M
Free cash flow (TTM)-144.27M
Dividends paid (TTM)58.80M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-37.38%
Return on Assets-20.87%
Return on Invested Capital-24.17%
Cash Return on Invested Capital-5.96%
COMPANY DETAILS
APHA (Tilray, Inc) company logo
Marketcap
5.46B
Marketcap category
Mid-cap
Description
Tilray Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The company offers cannabis-lifestyle and consumer packaged goods; and hemp-based foods and alcoholic beverages. It offers medical cannabis in extracts and dried flower forms; and cannabis extracts, including purified oil drops and capsules. The company supplies cannabis extract products to patients, physicians, pharmacies, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company was formerly known as Aphria Inc. and changed its name to Tilray, Inc. Tilray Inc. is based in Leamington, Canada.
Employees
1200
SEC filings
CEO
Irwin Simon
Country
USA
City
Leamington
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found